1 TRAZODONE HCL | 740 of 1,6630 | 1450 prescriptions Less than 1% of all prescriptions | 860 | 360 patients 21% of all patients | 230 patients 13% of all patients | |
2 GABAPENTIN | 3050 of 2,2800 | 920 prescriptions Less than 1% of all prescriptions | 810 | 240 patients 14% of all patients | < 11 | |
3 ZALEPLON | 10 of 300 | 1100 prescriptions Less than 1% of all prescriptions | 770 | 310 patients 18% of all patients | < 11 | |
4 PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DI-HCL) | 110 of 5600 | 750 prescriptions Less than 1% of all prescriptions | 490 | 230 patients 13% of all patients | < 11 | |
5 ZOLPIDEM TARTRATE | 590 of 1,3490 | 870 prescriptions Less than 1% of all prescriptions | 600 | 170 patients 10% of all patients | < 11 | |
6 ALPRAZOLAM | 2730 of 1,7940 | 560 prescriptions Less than 1% of all prescriptions | 310 | 120 patients 7% of all patients | < 11 | |
7 MODAFINIL | 10 of 550 | 570 prescriptions Less than 1% of all prescriptions | 350 | 140 patients 8% of all patients | < 11 | |
8 CLONAZEPAM | 1120 of 1,2250 | 300 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
9 TEMAZEPAM | 460 of 5450 | 320 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
10 ARMODAFINIL | 10 of 50 | 430 prescriptions Less than 1% of all prescriptions | 260 | < 11 | < 11 | |
11 ROPINIROLE HCL | 900 of 8440 | 230 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 CYCLOBENZAPRINE HCL | 1120 of 1,1780 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 BELSOMRA (SUVOREXANT) | 40 of 240 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 ESZOPICLONE | 140 of 1110 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 LUNESTA (ESZOPICLONE) | 30 of 30 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
16 DEXTROAMPHETAMINE-AMPHETAMINE (DEXTROAMPHETAMINE/AMPHETAMINE) | 560 of 2890 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |